| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c1b662dc0dc2b094c71df74b771bbbb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 |
| filingDate |
1981-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38fae602541d779e3da37b0f7da2b6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce468bca58cc7ef9def4796c94ab176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bed742ad43692e764a40c37aa4811584 |
| publicationDate |
1982-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0044188-A2 |
| titleOfInvention |
Synthesis of tumor antigenic determinant |
| abstract |
Processes are provided for the synthesis of the human T-antigenic determinant 2-acetamido-2-deo×y-3-O-(β-D-galactopyranosyl)-a-D-galactopyranoside containing an a-0-glycosidically linked bridging arm O-(CH<sub>2</sub>)<sub>n</sub>COR. The determinant is coupled to carrier molecules to form artificial T-antigens, and to insoluble supports to form T-immunoadsorbents. The artificial T-antigen is shown to elicit a delayed type hypersensitivity reaction as a diagnostic for the presence of cancer in humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0273388-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0096293-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111537315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0063373-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4767622-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5376531-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0273388-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0089939-A1 |
| priorityDate |
1980-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |